Atlas Trials

A Bioequivalence Study of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) Versus Advil Dual Action Caplets (125 mg/250 mg) and Bioavailability Assessment of Advil Dual Action Liquid Filled Capsules (125 mg/250 mg) and Advil Liqui-Gels (200 mg) in Healthy Adult Subjects

Clinical trial NCT06802185 · COMPLETED

Trial details

NCT number
NCT06802185
Sponsor
HALEON
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pain
Start date
2025-01-31
Primary completion
2025-04-12
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.